Literature DB >> 12067307

Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis.

J-S Lee1, C-H Song, C-H Kim, S-J Kong, M-H Shon, H-J Kim, J-K Park, T-H Paik, E-K Jo.   

Abstract

This study investigated the profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in response to a purified protein derivative (PPD) antigen in peripheral blood mononuclear cells (PBMC) from 18 HIV-negative patients with multidrug-resistant tuberculosis (MDRTB), and compared them with those from 19 healthy tuberculin reactors (HTR). ELISA results showed that following stimulation with PPD, IFN-gamma production was significantly reduced, whereas production of both IL-18 and IL-10 was significantly elevated in MDRTB patients compared with HTR. Three out of 18 patients with MDRTB of greater than 4 years duration showed significantly elevated IL-12 p70 production, induced by in vitro PPD stimulation of their PBMC, when compared with data from HTR. However, when taken as a group, MDRTB patients were similar to HTR in their IL-12 p70-producing capacity. IL-12 p70 protein paralleled IL-12 p40 protein expression. In addition, the production of IL-12 p40 was significantly correlated with IL-10 in all patients, but was not correlated with IFN-gamma. Neutralization of IL-10 increased IL-12 p40 about twofold, but did not significantly alter IFN-gamma induction in MDRTB. IFN-gamma in MDRTB was highly correlated with lymphoproliferation and CD4 counts, but was not correlated with IL-12, IL-18 or IL-10 production. Our findings suggest that patients with MDRTB have dysregulated IL-12, IL-18 and IL-10 production during Mycobacterium tuberculosis infection, and the cytokine profiles are similar to those in patients with drug-sensitive advanced TB previously reported in the literature. In addition, IL-10 may not have a dominant role in defective IFN-gamma production in patients with MDRTB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067307      PMCID: PMC1906259          DOI: 10.1046/j.1365-2249.2002.01858.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice.

Authors:  X Q Wei; B P Leung; W Niedbala; D Piedrafita; G J Feng; M Sweet; L Dobbie; A J Smith; F Y Liew
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  A role for IL-12 receptor expression and signal transduction in host defense in leprosy.

Authors:  J Kim; K Uyemura; M K Van Dyke; A J Legaspi; T H Rea; K Shuai; R L Modlin
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.

Authors:  S F Wolf; P A Temple; M Kobayashi; D Young; M Dicig; L Lowe; R Dzialo; L Fitz; C Ferenz; R M Hewick
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

4.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.

Authors:  I M Orme; A D Roberts; J P Griffin; J S Abrams
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

Review 5.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

Authors:  G Trinchieri
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

6.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

Authors:  M Goble; M D Iseman; L A Madsen; D Waite; L Ackerson; C R Horsburgh
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

Review 7.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

Review 8.  Interleukin-10.

Authors:  R de Waal Malefyt; H Yssel; M G Roncarolo; H Spits; J E de Vries
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  19 in total

1.  Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Jin-Hong Min; Hyun-Kyung Kwak; Min-Sun Hong; Ji-Hye Kong; Soo-Hee Hwang; Seung-Kyu Park; Jason J Leblanc; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

2.  Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.

Authors:  Alireza Hadizadeh Tasbiti; Shamsi Yari; Seyed Davar Siadat; Payam Tabarsi; Kayvan Saeedfar; Fatemeh Yari
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

3.  Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients.

Authors:  A Fortes; K Pereira; P R Z Antas; C L M C Franken; M Dalcolmo; M M Ribeiro-Carvalho; K S Cunha; A Geluk; A Kritski; A Kolk; P Klatser; E N Sarno; T H M Ottenhoff; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

4.  Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Andre Kipnis; Marcela Henao Tamayo; Marisa Harton; Mercedes Gonzalez Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

5.  Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India.

Authors:  Madhan Kumar; Jagadish C Sundaramurthi; Narinder K Mehra; Gurvinder Kaur; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402

6.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

7.  Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

Authors:  A S Shahemabadi; A Zavaran Hosseini; S Shaghsempour; M R Masjedi; M Rayani; M Pouramiri
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

8.  The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis.

Authors:  J-S Lee; C-H Song; J-H Lim; H-J Kim; J-K Park; T-H Paik; C-H Kim; S-J Kong; M-H Shon; S-S Jung; E-K Jo
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Authors:  R O Pinheiro; E B de Oliveira; G Dos Santos; G M Sperandio da Silva; B J de Andrade Silva; R M B Teles; A Milagres; E N Sarno; M P Dalcolmo; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

10.  Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains.

Authors:  Laura Geffner; Noemí Yokobori; Juan Basile; Pablo Schierloh; Luciana Balboa; María Mercedes Romero; Viviana Ritacco; Marisa Vescovo; Pablo González Montaner; Beatriz Lopez; Lucía Barrera; Mercedes Alemán; Eduardo Abatte; María C Sasiain; Silvia de la Barrera
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.